Navigation Links
Heart Drug Digoxin Tied to Higher Death Risk for Some Patients
Date:11/28/2012

WEDNESDAY, Nov. 28 (HealthDay News) -- The widely used heart drug digoxin is associated with an increased risk of death in people with the common heart rhythm disorder know as atrial fibrillation, a new study finds.

Researchers analyzed data from more than 4,000 patients with atrial fibrillation and found that digoxin was associated with a 41 percent increased risk of death from all causes, a 35 percent increased risk of death from cardiovascular causes, and a 61 percent increased risk of death from problems with the rate and rhythm of the heartbeat.

The findings mean that among patients with atrial fibrillation who take taking digoxin -- compared to those not taking digoxin -- one additional patient out of six will die from any cause over five years, one additional patient out of eight will die from cardiovascular causes, and one additional patient out of 16 will die from arrhythmias, the study authors said.

The study, led by Samy Claude Elayi, an associate professor of medicine at the Gill Heart Institute at the University of Kentucky, was published online Nov. 28 in the European Heart Journal.

Digoxin is found naturally in the foxglove plant, from which it is extracted. The drug helps the heart beat more strongly and with a more regular rhythm and is commonly used in both atrial fibrillation patients and heart failure patients. However, while the use of digoxin has been widely studied in heart failure patients, there's been a lack of data about its use in patients with the irregular heartbeat, according to the study authors.

They said their findings call into the question the widespread use of digoxin in atrial fibrillation patients.

"These findings mean that physicians should try to control a patient's heart rate by using alternatives as a first line, such as beta-blockers or calcium blockers; if digoxin is used, use a low dose with careful clinical follow-up, evaluate potential drug interactions when starting new medications, and monitor digoxin levels," the authors said "Patients should be aware of potential toxicity and see their physicians immediately in specific clinical situations, for instance if they experience palpitations or syncope (fainting), as those may precede arrhythmic death," they added.

The mechanism by which digoxin increased the risk of death in atrial fibrillation patients is unclear. And while the study noted an association between digoxin use and increased death risk in these patients, it could not prove a cause-and-effect relationship.

"Deaths from classic cardiovascular causes, whether due to arrhythmia or not, can partly but not entirely explain [the relationship]," Elayi and his colleagues wrote. "This suggests there must be some additional mechanism that remains to be identified."

More information

The U.S. National Heart, Lung, and Blood Institute has more about atrial fibrillation.

-- Robert Preidt

SOURCE: European Heart Journal, news release, Nov. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Heart Failure Drugs Put to the Test
2. Overactive Thyroid May Raise Risk for Common Irregular Heartbeat
3. High Blood Pressure During Pregnancy Tied to Later Heart Trouble
4. Tips for Holiday Heartburn Relief
5. Routine Checkups Dont Cut Cancer, Heart Deaths: Study
6. Unemployed at Higher Risk for Heart Attack?
7. Regular Exercise May Help Seniors Stave Off Heart Failure
8. Umbilical cord cells outperform bone marrow cells in repairing damaged hearts
9. Early Menstruation Tied to Factors That Raise Heart Disease Risk
10. Herceptin May Carry Higher Heart Risks for Women Than Thought
11. Heart failure in older breast cancer patients linked to medication
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Heart Drug Digoxin Tied to Higher Death Risk for Some Patients
(Date:2/9/2016)... Altamonte Springs, FL (PRWEB) , ... February 09, ... ... nation’s leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It ... donations for each prescription referral received at our specialty pharmacy. , “Since ...
(Date:2/9/2016)... ... February 09, 2016 , ... Dr. Rassouli, cosmetic dentist in Orange ... among the most popular cosmetic procedures in dentistry today, but the cost often leads ... them at risk of teeth whitening-related damage. For a limited time, Dr. Rassouli is ...
(Date:2/9/2016)... ... ... United Methodist Communications collaborated with Chocolate Moose Media and ... designed to prevent the next widespread Ebola outbreak from occurring in West ... Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African countries, with additional ...
(Date:2/8/2016)... ... 2016 , ... CURE Media Group , the nation’s leading digital and ... Heroes Awards event , which will annually honor individuals making heroic contributions in the ... MM Heroes Awards nomination process is officially open through February 17 for ...
(Date:2/8/2016)... Texas (PRWEB) , ... February 08, 2016 , ... The Valentine’s Season is famous for ... members and significant others that they are loved. This year, for more than 5.6 ... they cost - just won't be enough to remind them of the lives they’ve led ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Landauer, Inc. (NYSE: LDR ), a recognized ... outsourced medical physics services and high quality medical consumable ... first quarter ended December 31, 2015. ... Quarter Highlights , Revenue of $36.5 million compared ... , Domestic Radiation Measurement services revenues increased 2.8% year-over-year ...
(Date:2/9/2016)... Calif., Feb. 9, 2016  Sangamo BioSciences, Inc. ... genome editing, today reported its fourth quarter and ... in vivo therapeutic genome editing," said ... "Our zinc finger nuclease (ZFN) technology leads the ... the core competencies necessary to move our ground-breaking ...
(Date:2/9/2016)... , February 9, 2016 ... a collaboration with 10x Genomics to develop and ... biology and bioinformatics. --> QGEN ; ... with 10x Genomics to develop and promote comprehensive ... bioinformatics. --> QIAGEN N.V. (NASDAQ: ...
Breaking Medicine Technology: